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Community respiratory virus infections in the 
imunocompromised host 
S. Ghosh,” E. Whimbey and G. P Bodey 
*The University of Texas M.D. Anderson Cancer 
Center, Houston, Texas 
During the last 15 years community respiratory virus 
(CRV) infections have been recognized as a not in- 
frequent cause of serious illnesses in patients with 
acute leukemia and in bone marrow transplant (BMT) 
recipients. Most of the reported series include relatively 
small number of cases over a protracted period of time. 
During the last 3 years we became aware of the in- 
creasing number of these infections in our institution 
and hence, conducted a review to determine the 
incidence and outcome compared to our previous 
experience. Between July 2000 and March 2002, 321 
cases of CRV infections were diagnosed among adult 
patients with acute respiratory illnesses (ARI), the 
majority of whom were BMT recipients and patients 
with hematologic malignancies. There were 104 cases 
(32%) of respiratory syncytial viruses (RSV), 74 (23%) 
influenza A, 37 (12%) influenza B, 73 (23%) para- 
influenza and 33 cases (10%) of picornaviruses. The 
infection progressed to pneumonia in 113 cases (35%) 
of whom 33% had RSV, 32% influenza, 25% para- 
influenza and 11% picornaviruses. Overall pneumonia- 
associated mortality was 13% (RSV 19%, parainfluenza 
14%, influenza 8% and picornaviruses 8%). All the 
patients with pneumonia had radiographic evidence of 
pneumonia and virus was cultured from broncho- 
alveolar lavage fluids in 31 cases and in 84 cases diag- 
nosis was made only from nasopharyngeal wash/throat 
swab specimens. There was no standardized treatment 
utilized but patients who received early treatment with 
aerosolized ribavirin with IVIG and/or palivizumab for 
RSV and oseltamivir for influenza and parainfluenza 
viruses appeared to have reduced progression to 
pneumonia and reduced pneumonia-associated mor- 
tality. During the earlier period between 1992-1994, the 
frequency of progression of CRV infections to pneu- 
monia and the mortality rates were substantially higher 
( RSV 38% and 60%, influenza 53% and 46% and 
parainfluenza 44% and 37% respectively). In conclusion, 
early diagnosis and treatment is associated with better 
outcome in adults with acute leukemia and BMT 
recipients who develop ARI. 
Hepatitis C infection in hemodialysis patients 
A. M. Vedjakov, VA. Gavrilin, N. I. Razlivaeva, 
A. G. Tonevitsky 
Institute of Transplantology and Artificial Organs, 
Moscow, Russia 
Patients with chronic kidney failure receiving program- 
mable hemodialysis therapy suffer from immuno- 
deficiency. Chronic intoxication and some peculiarities 
in homeostasis of these patients may have a substantial 
influence on the course of viral infections, hepatitis C 
virus (HCV) infection in particular. 
Objectives: The study of the differences in the course of 
HCV infection in hemodialysis and immunocompetent 
patients. 
Methods: 28 hemodialysis patients and 30 immuno- 
competent patients, anti-HCV seropositive, were studied. 
In hemodialysis patients, two blood samples were studied 
in parallel, one taken before, and another one after 
hemodialysis. HCV RNA in plasma was detected by 
nested-PCR (RT-PCR) method. Primers, comple- 
mentary to 5’ non-translated region, were used. Vaccine 
strain of measles virus was used as a non-competent 
internal control in PCR analysis. Semi-quantitative 
assessment of PCR results was carried out by limiting 
dilutions of samples. HCV-specific IgM, IgG antibodies 
and antibodies against viral proteins core, NS3, NS4, and 
NS5 were detected by ELISA. 
Results: Among 30 immunocompetent anti-HCV 
seropositive patients, HCV RNA was detected in 29 
(90%) and anti-HCV IgM in 21 (70%). Among 28 
hemodialysis anti-HCV seropositive patients, HCV 
RNA was detected in 19 (68%), and anti-HCV IgM in 
11 (39%). The results of PCR analysis of blood samples 
before and after hemodialysis were identical. The levels 
of viral load in the group of hemodialysis patients 
with HCV viremia were also lower compared with 
control group. Comparative analysis of humoral immune 
response to HCV viral proteins core, NS3, NS4, and NS5 
did not show substantial differences between the control 
group and the group of hemodialysis patients. Among 
anti-HCV seropositive hemodialysis patients, 63% of 
those without HCV viremia exhibited HLA phenotype 
DR5+, while only 33% of those with HCV viremia 
exhibited the same phenotype. 
Conclusion: A peculiar course of chronic hepatitis C 
virus (HCV) infection in hemodialysis patients had been 
revealed. In such anti-HCV seropositive patients, a 
viremia appeared significantly rare (in 68% cases) in 
comparison with a usual population of seropositive anti- 
HCV patients (in 90% cases). 
Oncogenic type of human papilioma virus (HPV) 
revealed by PCR in the oral mucosa of the kidney 
allograft recipients 
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The aim of the study was to assess changes in the 
oral cavity of kidney allograft recipients under chronic 
immunosuppression (Cyclosporin A, Azathioprine and 
